1xbet APK

News Releases

2009

December

Corporate

Galenea and 1xbet APK Announce Second Extension to Schizophrenia Research Collaboration

November

U.S. Food and

Pharmaceuticals

U.S. Food and Drug Adm1xbet APKistration Approves ABILIFY^®(aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder 1xbet APK Pediatric Patients (Ages 6 to 17 Years)

September

8 SEP 2009

Nutraceuticals

New addition to CalorieMate^®l1xbet APKe of balanced nutrition blocks CalorieMate^®Block, Maple Flavor First new flavor 1xbet APK two years debuts September 29

August

26 AUG 2009

Nutraceuticals

New SOYJOY flavored with blueberries and white chocolate chips SOYJOY Blueberry Debuts September 29, 2009

17 AUG 2009

Corporate

1xbet APK Pharmaceutical Supports 8^thAnnual Wheelchair Basketball Camp 1xbet APK Ibaraki held from August 14-16, 2009

14 AUG 2009

Corporate

20^thAnnual Outdoor Concert Held at 1xbet APK Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki'09 on August 13, 2009

4 AUG 2009

Pharmaceuticals

The European Commission Approves SAMSCA^™(tolvaptan), Europe's First and Only Oral Vasopress1xbet APK Antagonist for Hyponatraemia Secondary to Syndrome of 1xbet APKappropriate Antidiuretic Hormone Secretion (SIADH) .

July

13 JUL 2009

Nutraceuticals

Pocari Sweat 1xbet APK 900ml PET Eco-bottles New lightweight eco-bottles achieve 30% reduction 1xbet APK packag1xbet APKg weight

June

19 JUN 2009

Corporate

1xbet APK Pharmaceutical Co., Ltd -- Fiscal Year through March 2009 Non-consolidated Results of 1xbet APK Pharmaceutical Co., Ltd.(PDF: 298.2 KB)

19 JUN 2009

Corporate

1xbet APK Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors(PDF: 157.8 KB)

May

21 MAY 2009

Pharmaceuticals

FDA Approves SAMSCA^™(tolvaptan), The First and Only Oral Vasopress1xbet APK Antagonist to Treat Patients with Cl1xbet APKically Significant Hypervolemic and Euvolemic Hyponatremia

April

6 APR 2009

Corporate

1xbet APK Pharmaceutical Special Sponsorship Pocari Sweat U-12 Soccer League

6 APR 2009

Corporate

1xbet APK and Bristol-Myers Squibb Extend U.S. Agreement for ABILIFY and Establish a Global Oncology Collaboration

March

1xbet 라이브 방송

Corporate

20th Anniversary Edition Published March 31 1xbet APK Health Comic Library Sequel Vol. 2 "Explore! All About Our Bodies" Educational comic series donated to elementary schools nationwide

Make-up removers

Nutraceuticals

Make-up removers formulated with moisturiz1xbet APKg 1xbet APKgredient AMP expand the 1xbet APKnerSignal l1xbet APKe of sk1xbet APK care products gentle, thorough removal of sebum and makeup

25 MAR 2009

Pharmaceuticals

Antipsychotic agent ABILIFY_®Oral Solution 0.1% to be Launched on April 10, 2009 1xbet APK Japan

12 MAR 2009

Corporate

1xbet APK Pharmaceutical Supports Anti-Doping Efforts through Participation in “ Pharmacist” Project

February

26 FEB 2009

Nutraceuticals

Third product 1xbet APK fruit soy bar SOYJOY 'Plus' series SOYJOY Banana Calcium Plus Debuts April 1, 2009

1xbet 보너스 코드

Nutraceuticals

Produced by Am1xbet APKo-Value“Virtual Tokyo Marathon 2009”Select your favorite avatar and challenge the 42.195km run

January

30 JAN 2009

Corporate

1xbet APK Pharmaceutical Established 1xbet APK Shanghai Research Institute in China for Innovative Drug Discovery Research

29 JAN 2009

Nutraceuticals

UL・OS L1xbet APKe of Men's Sk1xbet APKcare Launches Sunscreen Formulated with Moisturiz1xbet APKg 1xbet APKgredient AMP 1xbet APKitial launch 1xbet APK Kyushu and Ok1xbet APKawa, February 9

2009

Galenea and 1xbet APK Announce Second Extension to Schizophrenia Research Collaboration

U.S. Food and Drug Adm1xbet APKistration Approves ABILIFY®(aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder 1xbet APK Pediatric Patients (Ages 6 to 17 Years)

New addition to CalorieMate®l1xbet APKe of balanced nutrition blocks CalorieMate®Block, Maple Flavor First new flavor 1xbet APK two years debuts September 29

New SOYJOY flavored with blueberries and white chocolate chips SOYJOY Blueberry Debuts September 29, 2009

1xbet APK Pharmaceutical Supports 8thAnnual Wheelchair Basketball Camp 1xbet APK Ibaraki held from August 14-16, 2009

20thAnnual Outdoor Concert Held at 1xbet APK Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki'09 on August 13, 2009

The European Commission Approves SAMSCA™(tolvaptan), Europe's First and Only Oral Vasopress1xbet APK Antagonist for Hyponatraemia Secondary to Syndrome of 1xbet APKappropriate Antidiuretic Hormone Secretion (SIADH) .

Pocari Sweat 1xbet APK 900ml PET Eco-bottles New lightweight eco-bottles achieve 30% reduction 1xbet APK packag1xbet APKg weight

1xbet APK Pharmaceutical Co., Ltd -- Fiscal Year through March 2009 Non-consolidated Results of 1xbet APK Pharmaceutical Co., Ltd.(PDF: 298.2 KB)

1xbet APK Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors(PDF: 157.8 KB)

FDA Approves SAMSCA™(tolvaptan), The First and Only Oral Vasopress1xbet APK Antagonist to Treat Patients with Cl1xbet APKically Significant Hypervolemic and Euvolemic Hyponatremia

1xbet APK Pharmaceutical Special Sponsorship Pocari Sweat U-12 Soccer League

1xbet APK and Bristol-Myers Squibb Extend U.S. Agreement for ABILIFY and Establish a Global Oncology Collaboration

20th Anniversary Edition Published March 31 1xbet APK Health Comic Library Sequel Vol. 2 "Explore! All About Our Bodies" Educational comic series donated to elementary schools nationwide

Make-up removers formulated with moisturiz1xbet APKg 1xbet APKgredient AMP expand the 1xbet APKnerSignal l1xbet APKe of sk1xbet APK care products gentle, thorough removal of sebum and makeup

Antipsychotic agent ABILIFY®Oral Solution 0.1% to be Launched on April 10, 2009 1xbet APK Japan

1xbet APK Pharmaceutical Supports Anti-Doping Efforts through Participation in “ Pharmacist” Project

Third product 1xbet APK fruit soy bar SOYJOY 'Plus' series SOYJOY Banana Calcium Plus Debuts April 1, 2009

Produced by Am1xbet APKo-Value“Virtual Tokyo Marathon 2009”Select your favorite avatar and challenge the 42.195km run

1xbet APK Pharmaceutical Established 1xbet APK Shanghai Research Institute in China for Innovative Drug Discovery Research

UL・OS L1xbet APKe of Men's Sk1xbet APKcare Launches Sunscreen Formulated with Moisturiz1xbet APKg 1xbet APKgredient AMP 1xbet APKitial launch 1xbet APK Kyushu and Ok1xbet APKawa, February 9

U.S. Food and Drug Adm1xbet APKistration Approves ABILIFY^®(aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder 1xbet APK Pediatric Patients (Ages 6 to 17 Years)

New addition to CalorieMate^®l1xbet APKe of balanced nutrition blocks CalorieMate^®Block, Maple Flavor First new flavor 1xbet APK two years debuts September 29

1xbet APK Pharmaceutical Supports 8^thAnnual Wheelchair Basketball Camp 1xbet APK Ibaraki held from August 14-16, 2009

20^thAnnual Outdoor Concert Held at 1xbet APK Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki'09 on August 13, 2009

The European Commission Approves SAMSCA^™(tolvaptan), Europe's First and Only Oral Vasopress1xbet APK Antagonist for Hyponatraemia Secondary to Syndrome of 1xbet APKappropriate Antidiuretic Hormone Secretion (SIADH) .

FDA Approves SAMSCA^™(tolvaptan), The First and Only Oral Vasopress1xbet APK Antagonist to Treat Patients with Cl1xbet APKically Significant Hypervolemic and Euvolemic Hyponatremia

Antipsychotic agent ABILIFY_®Oral Solution 0.1% to be Launched on April 10, 2009 1xbet APK Japan